These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7331055)

  • 21. Urine protein markers distinguish stone-forming from non-stone-forming relatives of calcium stone formers.
    Bergsland KJ; Kelly JK; Coe BJ; Coe FL
    Am J Physiol Renal Physiol; 2006 Sep; 291(3):F530-6. PubMed ID: 16622176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers.
    Massey LK; Sutton RA
    J Urol; 2004 Aug; 172(2):555-8. PubMed ID: 15247728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperoxaluria in idiopathic calcium nephrolithiasis--what are the limits?
    Osther PJ
    Scand J Urol Nephrol; 1999 Dec; 33(6):368-71. PubMed ID: 10636575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism.
    Parks JH; Coe FL; Evan AP; Worcester EM
    BJU Int; 2009 Mar; 103(5):670-8. PubMed ID: 18793297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function.
    Jaggi M; Nakagawa Y; Zipperle L; Hess B
    Urol Res; 2007 Apr; 35(2):55-62. PubMed ID: 17345077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Sep; 34(9):1543-7. PubMed ID: 3213790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium crystalluria in recurrent renal-stone formers.
    Robertson WG; Peacock M; Nordin BE
    Lancet; 1969 Jul; 2(7610):21-4. PubMed ID: 4182793
    [No Abstract]   [Full Text] [Related]  

  • 29. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Crystalluria].
    Daudon M
    Nephrol Ther; 2015 Jun; 11(3):174-90. PubMed ID: 25934324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystalluria in marathon runners. III. Stone-forming subjects.
    Rodgers AL; Greyling KG; Noakes TD
    Urol Res; 1991; 19(3):189-92. PubMed ID: 1887527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.
    Robertson WG
    Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].
    Lagemann M; Anders D; Graef V; Bödeker RH
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):754-9. PubMed ID: 4069117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
    Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High urinary calcium excretion and genetic susceptibility to hypertension and kidney stone disease.
    Mente A; Honey RJ; McLaughlin JM; Bull SB; Logan AG
    J Am Soc Nephrol; 2006 Sep; 17(9):2567-75. PubMed ID: 16855017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial aggregation of renal calcium stone disease.
    Trinchieri A; Mandressi A; Luongo P; Coppi F; Pisani E
    J Urol; 1988 Mar; 139(3):478-81. PubMed ID: 3343730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors.
    Caudarella R; Vescini F; Buffa A; Sinicropi G; Rizzoli E; La Manna G; Stefoni S
    J Nephrol; 2003; 16(2):260-6. PubMed ID: 12768074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiological studies in hypercalciuric and normocalciuric stone formers.
    Minisola S; Scarda A; Medori C; Valtorta C; Antonelli R; Tabolli S; Rossi W; Mazzuoli G
    Urol Int; 1985; 40(2):65-71. PubMed ID: 3992738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones.
    Khan SR; Glenton PA; Backov R; Talham DR
    Kidney Int; 2002 Dec; 62(6):2062-72. PubMed ID: 12427130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies of urinary risk factors in urolithiasis].
    Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
    Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.